Delivery Order SPE2DB22D2006-SPE2DB25FW3DY
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $9.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $10,187.98 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $25,977.38 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets in quantities of 30, with an ultimate completion date of November 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,247.09 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 250 mg tablets (30-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of August 20, 2025, and represents fulfillment under AmerisourceBergen's larger pharmaceutical supply framework. The contract involves no set-aside designation and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,702.10 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.99 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,389.64 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count) under a firm fixed price contract type. The award, made on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,882.88 to AmerisourceBergen Drug Corp for Lamictal XR 300 mg tablets (quantity: 30-count packages) on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,432.53 on July 22, 2025, for Lamictal XR 250 mg tablets (30-count packages). The contract is a firm fixed price delivery order without set-aside designation, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $9,871.83, with an ultimate completion date of October 31, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement supporting federal medical supply requirements. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $8,951.56 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Lamictal XR 300 mg tablets, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...